Combination Chemotherapy, Radiation Therapy, and Bone Marrow Transplantation in Treating Patients With Retinoblastoma
Completed · Phase 2
Conditions studied: Retinoblastoma
In brief
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. Bone marrow transplantation may allow the doctor to give higher doses of chemotherapy drugs and kill more tumor cells. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy plus radiation therapy followed by bone marrow transplantation in treating patients who have retinoblastoma.
Key facts
- Study ID
- NCT00004006
- Run by
- St. Jude Children's Research Hospital
- People needed
- 4
- Starts
- 1997-11-01
- Expected to finish
- 2005-09-01
- Last updated by the study team
- 2011-10-04
Who can join
Age: any, up to 15. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St. Jude Children's Research Hospital — Memphis, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.